2.4.0.8000490 - Disclosure - Stock-Based Compensation: Schedule of Share-Based Compensation Activity (Tables)truefalsefalse1false falsefalseD120401_130331http://www.sec.gov/CIK0001011060duration2012-04-01T00:00:002013-03-31T00:00:001true 1us-gaap_TableTextBlockSupplementAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Tables/Schedules2false 2us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  <table border="0" cellspacing="0" cellpadding="0" width="580" style='width:435.35pt;border-collapse:collapse'> <tr align="left"> <td width="228" valign="bottom" style='width:171.0pt;padding:.7pt .7pt 0in .7pt'>   </td> <td width="76" valign="bottom" style='width:56.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:.7pt .7pt 0in .7pt'> Options Outstanding </td> <td width="97" valign="bottom" style='width:72.75pt;border:none;border-bottom:solid windowtext 1.0pt;padding:.7pt .7pt 0in .7pt'> Weighted-Average Exercise Price per Share </td> <td width="84" valign="bottom" style='width:62.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:.7pt .7pt 0in .7pt'> Weighted-Average Remaining Contractual Term in Years </td> <td width="96" valign="bottom" style='width:71.75pt;border:none;border-bottom:solid windowtext 1.0pt;padding:.7pt .7pt 0in .7pt'> Aggregate Intrinsic Value (in thousands) </td> </tr> <tr align="left"> <td width="228" valign="bottom" style='width:171.0pt;padding:.7pt .7pt 0in .7pt'> Options outstanding as of April 1, 2012 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> 2,130,119 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> $1.03 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'></td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'></td> </tr> <tr align="left"> <td width="228" valign="bottom" style='width:171.0pt;padding:.7pt .7pt 0in .7pt'> Granted </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> - </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> -   </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'>    </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'></td> </tr> <tr align="left"> <td width="228" valign="bottom" style='width:171.0pt;padding:.7pt .7pt 0in .7pt'> Exercised </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> - </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> -   </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'></td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'></td> </tr> <tr align="left"> <td width="228" valign="bottom" style='width:171.0pt;padding:.7pt .7pt 0in .7pt'> Cancelled or forfeited </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> (285,619) </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> 1.29 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'></td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'></td> </tr> <tr align="left"> <td width="228" valign="bottom" style='width:171.0pt;padding:.7pt .7pt 0in .7pt'> Options outstanding as of March 31, 2013 </td> <td valign="bottom" style='border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 2.25pt;border-right:none;padding:.7pt .7pt 0in .7pt'> 1,844,500 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> .99 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> 5.36 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> $- </td> </tr> <tr align="left"> <td width="228" valign="bottom" style='width:171.0pt;padding:.7pt .7pt 0in .7pt'> Options exercisable as of March 31, 2013 </td> <td valign="bottom" style='border:none;border-bottom:double windowtext 2.25pt;padding:.7pt .7pt 0in .7pt'> 1,744,500 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> 1.03 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> 5.25 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> $- </td> </tr> <tr align="left"> <td width="228" valign="bottom" style='width:171.0pt;padding:.7pt .7pt 0in .7pt'> Options vested or expected to vest as of March 31, 2013 </td> <td valign="bottom" style='border:none;border-bottom:double windowtext 2.25pt;padding:.7pt .7pt 0in .7pt'> 1,844,500 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> .99 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> 5.36 </td> <td valign="bottom" style='padding:.7pt .7pt 0in .7pt'> $- </td> </tr> </table>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value.No definition available.false0Schedule of Share-Based Compensation ActivityfalseStock-Based Compensation: Schedule of Share-Based Compensation Activity (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.advbiomaterials.com/20130331/role/idr_DisclosureStockBasedCompensationScheduleOfShareBasedCompensationActivityTables12